Pharmacokinetics of fentanyl following intravenous and transdermal administration in horses

L. K. Maxwell, Sara M Thomasy, N. Slovis, C. Kollias-Baker

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Reasons for performing study: Although fentanyl has been reported to cause CNS excitation in horses, a transdermal therapeutic system (TTS) containing this mu agonist has recently been used empirically in equine medicine to treat moderate to severe pain. A better understanding of the disposition of fentanyl following transdermal administration would facilitate the clinical use of TTS fentanyl to obtain analgesia in horses. Objectives: To determine the pharmacokinetics of fentanyl following i.v. and TTS patch administration in healthy, mature horses and to evaluate the tolerance of horses to TTS fentanyl administration. Methods: The pharmacokinetics of fentanyl in serum were assessed following a single i.v. dose, a single TTS dose, and multiple TTS doses in 6 healthy horses. Physical examinations, haematology and serum biochemistry analyses during transdermal fentanyl application were then performed to determine tolerance of continuous fentanyl administration. Results: Fentanyl was very rapidly and completely absorbed following a single TTS dose. Mean serum fentanyl concentrations consistent with analgesia in other species were reached by 1 h and maintained until 32 h after patch application. Similar steady state serum concentrations were obtained when multiple doses of TTS fentanyl were administered every 48 or 72 h over 8 or 9 days, with less fluctuation in serum concentrations during the 48 h dosing interval. Three horses exhibited brief (<12 h) episodes of increased body temperature; however, transdermal fentanyl administrations were not associated with other significant changes in haematology and biochemistry panels or physical examination findings. Conclusions and potential relevance: Although the pharmacodynamics of fentanyl have not been investigated fully in horses, transdermally-administered fentanyl exhibited a favourable pharmacokinetic profile without clinically relevant side effects and may be a useful analgesic in equine patients.

Original languageEnglish (US)
Pages (from-to)484-490
Number of pages7
JournalEquine Veterinary Journal
Volume35
Issue number5
StatePublished - Jul 2003

Fingerprint

Cutaneous Administration
fentanyl
Fentanyl
Intravenous Administration
pharmacokinetics
Horses
Pharmacokinetics
horses
therapeutics
dosage
Serum
Hematology
hematology
analgesia
Biochemistry
biochemistry
clinical examination
Analgesia
Therapeutics
Physical Examination

Keywords

  • Absorption
  • Analgesia
  • Horse
  • Loo-Riegelman
  • Opioids
  • Pharmacokinetics
  • Transdermal

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Pharmacokinetics of fentanyl following intravenous and transdermal administration in horses. / Maxwell, L. K.; Thomasy, Sara M; Slovis, N.; Kollias-Baker, C.

In: Equine Veterinary Journal, Vol. 35, No. 5, 07.2003, p. 484-490.

Research output: Contribution to journalArticle

Maxwell, L. K. ; Thomasy, Sara M ; Slovis, N. ; Kollias-Baker, C. / Pharmacokinetics of fentanyl following intravenous and transdermal administration in horses. In: Equine Veterinary Journal. 2003 ; Vol. 35, No. 5. pp. 484-490.
@article{22b1a4196cc24367b15d1ff858bc6acf,
title = "Pharmacokinetics of fentanyl following intravenous and transdermal administration in horses",
abstract = "Reasons for performing study: Although fentanyl has been reported to cause CNS excitation in horses, a transdermal therapeutic system (TTS) containing this mu agonist has recently been used empirically in equine medicine to treat moderate to severe pain. A better understanding of the disposition of fentanyl following transdermal administration would facilitate the clinical use of TTS fentanyl to obtain analgesia in horses. Objectives: To determine the pharmacokinetics of fentanyl following i.v. and TTS patch administration in healthy, mature horses and to evaluate the tolerance of horses to TTS fentanyl administration. Methods: The pharmacokinetics of fentanyl in serum were assessed following a single i.v. dose, a single TTS dose, and multiple TTS doses in 6 healthy horses. Physical examinations, haematology and serum biochemistry analyses during transdermal fentanyl application were then performed to determine tolerance of continuous fentanyl administration. Results: Fentanyl was very rapidly and completely absorbed following a single TTS dose. Mean serum fentanyl concentrations consistent with analgesia in other species were reached by 1 h and maintained until 32 h after patch application. Similar steady state serum concentrations were obtained when multiple doses of TTS fentanyl were administered every 48 or 72 h over 8 or 9 days, with less fluctuation in serum concentrations during the 48 h dosing interval. Three horses exhibited brief (<12 h) episodes of increased body temperature; however, transdermal fentanyl administrations were not associated with other significant changes in haematology and biochemistry panels or physical examination findings. Conclusions and potential relevance: Although the pharmacodynamics of fentanyl have not been investigated fully in horses, transdermally-administered fentanyl exhibited a favourable pharmacokinetic profile without clinically relevant side effects and may be a useful analgesic in equine patients.",
keywords = "Absorption, Analgesia, Horse, Loo-Riegelman, Opioids, Pharmacokinetics, Transdermal",
author = "Maxwell, {L. K.} and Thomasy, {Sara M} and N. Slovis and C. Kollias-Baker",
year = "2003",
month = "7",
language = "English (US)",
volume = "35",
pages = "484--490",
journal = "Equine veterinary journal. Supplement",
issn = "2042-3306",
publisher = "British Equine Veterinary Association",
number = "5",

}

TY - JOUR

T1 - Pharmacokinetics of fentanyl following intravenous and transdermal administration in horses

AU - Maxwell, L. K.

AU - Thomasy, Sara M

AU - Slovis, N.

AU - Kollias-Baker, C.

PY - 2003/7

Y1 - 2003/7

N2 - Reasons for performing study: Although fentanyl has been reported to cause CNS excitation in horses, a transdermal therapeutic system (TTS) containing this mu agonist has recently been used empirically in equine medicine to treat moderate to severe pain. A better understanding of the disposition of fentanyl following transdermal administration would facilitate the clinical use of TTS fentanyl to obtain analgesia in horses. Objectives: To determine the pharmacokinetics of fentanyl following i.v. and TTS patch administration in healthy, mature horses and to evaluate the tolerance of horses to TTS fentanyl administration. Methods: The pharmacokinetics of fentanyl in serum were assessed following a single i.v. dose, a single TTS dose, and multiple TTS doses in 6 healthy horses. Physical examinations, haematology and serum biochemistry analyses during transdermal fentanyl application were then performed to determine tolerance of continuous fentanyl administration. Results: Fentanyl was very rapidly and completely absorbed following a single TTS dose. Mean serum fentanyl concentrations consistent with analgesia in other species were reached by 1 h and maintained until 32 h after patch application. Similar steady state serum concentrations were obtained when multiple doses of TTS fentanyl were administered every 48 or 72 h over 8 or 9 days, with less fluctuation in serum concentrations during the 48 h dosing interval. Three horses exhibited brief (<12 h) episodes of increased body temperature; however, transdermal fentanyl administrations were not associated with other significant changes in haematology and biochemistry panels or physical examination findings. Conclusions and potential relevance: Although the pharmacodynamics of fentanyl have not been investigated fully in horses, transdermally-administered fentanyl exhibited a favourable pharmacokinetic profile without clinically relevant side effects and may be a useful analgesic in equine patients.

AB - Reasons for performing study: Although fentanyl has been reported to cause CNS excitation in horses, a transdermal therapeutic system (TTS) containing this mu agonist has recently been used empirically in equine medicine to treat moderate to severe pain. A better understanding of the disposition of fentanyl following transdermal administration would facilitate the clinical use of TTS fentanyl to obtain analgesia in horses. Objectives: To determine the pharmacokinetics of fentanyl following i.v. and TTS patch administration in healthy, mature horses and to evaluate the tolerance of horses to TTS fentanyl administration. Methods: The pharmacokinetics of fentanyl in serum were assessed following a single i.v. dose, a single TTS dose, and multiple TTS doses in 6 healthy horses. Physical examinations, haematology and serum biochemistry analyses during transdermal fentanyl application were then performed to determine tolerance of continuous fentanyl administration. Results: Fentanyl was very rapidly and completely absorbed following a single TTS dose. Mean serum fentanyl concentrations consistent with analgesia in other species were reached by 1 h and maintained until 32 h after patch application. Similar steady state serum concentrations were obtained when multiple doses of TTS fentanyl were administered every 48 or 72 h over 8 or 9 days, with less fluctuation in serum concentrations during the 48 h dosing interval. Three horses exhibited brief (<12 h) episodes of increased body temperature; however, transdermal fentanyl administrations were not associated with other significant changes in haematology and biochemistry panels or physical examination findings. Conclusions and potential relevance: Although the pharmacodynamics of fentanyl have not been investigated fully in horses, transdermally-administered fentanyl exhibited a favourable pharmacokinetic profile without clinically relevant side effects and may be a useful analgesic in equine patients.

KW - Absorption

KW - Analgesia

KW - Horse

KW - Loo-Riegelman

KW - Opioids

KW - Pharmacokinetics

KW - Transdermal

UR - http://www.scopus.com/inward/record.url?scp=0642344586&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0642344586&partnerID=8YFLogxK

M3 - Article

C2 - 12875327

AN - SCOPUS:0642344586

VL - 35

SP - 484

EP - 490

JO - Equine veterinary journal. Supplement

JF - Equine veterinary journal. Supplement

SN - 2042-3306

IS - 5

ER -